Aurinia Pharmaceuticals Inc

(AUPH) Trade

By |

Profile

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for the patients suffering from serious diseases with high unmet medical need. The firm particularly develops a therapeutic drug to treat autoimmune diseases in particular lupus nephritis. Its main product candidate is Voclosporin.

Contact Information

Website: www.auriniapharma.com
Email: dbourgeault@auriniapharma.com
Main Phone: +1 250 744-2487
Address: 4464 Markham Street
Address 2: Suite 1203
State: BC
City / Town: Victoria
Country: CAN
Postal Code: V8Z 7X8

Issuer Information

Exchange: NSD
CEO: Richard M. Glickman
Employees: 33
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 6.13 $ -0.06 (-0.97%)
Last Price 6.13 Change $ -0.06 Change % -0.97 Tick N/A
Bid 6.12 Bid Size 100.00 Ask 6.14 Ask Size 800.00
Open 6.18 High 6.23 Low 6.12 Prev Close 6.19
Last Trade Volume 78,478 52 Wk Hi 6.69 52 Wk Low 4.41
Market Cap 523.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 85,343,167.00 EPS (TTM) -0.59 PE Ratio N/A Exchange NSD
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 16 16 16 16
Low Target Price Estimate 9 9 9 9
Mean Target Price Estimate 12 12 12 12
Standard Deviation 2.61 2.61 2.61 2.61
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 2 2 2 2
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.41 1.41 1.41 1.41